HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexander Zoufaly Selected Research

Alexander Zoufaly Research Topics

Disease

37COVID-19
11/2023 - 01/2020
11Infections
03/2023 - 01/2006
4Disease Progression
01/2023 - 05/2021
3Inflammation (Inflammations)
03/2023 - 10/2021
2Candidemia
03/2024 - 12/2022
2Neoplasms (Cancer)
01/2023 - 05/2021
2Breakthrough Infections
10/2022 - 01/2022
2Pneumonia (Pneumonitis)
12/2021 - 05/2021
2Anemia
05/2021 - 04/2020
2Lymphoma (Lymphomas)
01/2018 - 07/2009
2AIDS-Related Lymphoma (Lymphoma, AIDS Related)
01/2018 - 07/2009
2Viremia
09/2013 - 07/2009
1Post-Acute COVID-19 Syndrome
02/2023
1Bradycardia
01/2023
1Animal Disease Models
01/2023
1Delirium
01/2023
1Superinfection
12/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
04/2022
1Virus Diseases (Viral Diseases)
01/2022
1Thromboinflammation
12/2021
1Thrombophilia
12/2021
1Myalgia
10/2021
1Chronic Renal Insufficiency
05/2021
1Chronic Obstructive Pulmonary Disease (COPD)
05/2021
1Transfusion Reaction
05/2021
1Hypersensitivity (Allergy)
05/2021
1Diabetes Mellitus
05/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2021
1Body Weight (Weight, Body)
05/2021
1Pancreatitis
05/2021
1Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2021
1IgA Deficiency
05/2021

Drug/Important Bio-Agent (IBA)

7Oxygen (Dioxygen)IBA
08/2023 - 11/2020
5AntibodiesIBA
01/2022 - 09/2013
4AntigensIBA
10/2023 - 01/2021
4Antiviral Agents (Antivirals)IBA
01/2023 - 01/2021
3Peptides (Polypeptides)IBA
10/2023 - 01/2021
3Immunoglobulin G (IgG)IBA
03/2023 - 01/2020
3sotrovimabIBA
01/2023 - 10/2022
3remdesivirIBA
12/2022 - 11/2020
3C-Reactive ProteinIBA
05/2021 - 04/2020
2AutoantigensIBA
10/2023 - 01/2021
2Dexamethasone (Maxidex)FDA LinkGeneric
08/2023 - 01/2023
2CytokinesIBA
01/2023 - 11/2021
2N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2023 - 01/2022
2N-(2-cyanoethylene)urea (BA 1)IBA
01/2023 - 01/2022
2VaccinesIBA
10/2022 - 01/2022
2Biomarkers (Surrogate Marker)IBA
10/2022 - 12/2021
2Monoclonal AntibodiesIBA
10/2022 - 04/2022
2RNA (Ribonucleic Acid)IBA
10/2022 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2019
2Neutralizing AntibodiesIBA
01/2022 - 01/2022
2Ritonavir (Norvir)FDA Link
04/2021 - 01/2021
2LopinavirFDA Link
04/2021 - 01/2021
2EnzymesIBA
01/2021 - 01/2020
2Immunoglobulin M (IgM)IBA
01/2021 - 01/2020
2ImmunosorbentsIBA
01/2021 - 01/2020
1Angiotensin-Converting Enzyme 2IBA
11/2023
1Surface-Active Agents (Surfactants)IBA
10/2023
1Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA
10/2023
1IgA receptor (protein B)IBA
10/2023
1Protein CIBA
10/2023
1baricitinibIBA
08/2023
1tocilizumab (atlizumab)FDA Link
08/2023
1pro-brain natriuretic peptide (1-76)IBA
02/2023
1molnupiravirIBA
01/2023
1nirmatrelvirIBA
01/2023
1Angiotensin IIBA
11/2022
1angiotensin I (1-7)IBA
11/2022
1Angiotensin IIIBA
11/2022
1AngiotensinsIBA
11/2022
1tixagevimabIBA
10/2022
1cilgavimabIBA
10/2022
1imdevimabIBA
10/2022
1Viral RNAIBA
10/2022
1Broadly Neutralizing AntibodiesIBA
01/2022
1mRNA VaccinesIBA
01/2022
1ClinitestIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Natural Killer Cell ReceptorsIBA
01/2022
1Adenosine Monophosphate (AMP)IBA
01/2022
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2021
1Cell-Free Nucleic AcidsIBA
12/2021
1fibrin fragment D (D-dimer)IBA
12/2021
1N(4)-oleylcytosine arabinosideIBA
12/2021
1Anti-Bacterial Agents (Antibiotics)IBA
12/2021
1Oseltamivir (Tamiflu)FDA Link
12/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021
1Interleukin-8 (Interleukin 8)IBA
11/2021
1Interleukin-6 (Interleukin 6)IBA
11/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2021
1Capsules (Microcapsules)IBA
05/2021

Therapy/Procedure

9Therapeutics
03/2024 - 01/2018
7Length of Stay
02/2023 - 01/2021
3Artificial Respiration (Mechanical Ventilation)
04/2022 - 01/2021
2Vagus Nerve Stimulation
01/2023 - 01/2022
2Contraindications
12/2021 - 05/2021
1Noninvasive Ventilation
11/2021
1Cannula
05/2021